Globally, the rise of more informed healthcare consumers, new technologies, and ubiquity of data and analytics
continues to blur the traditional boundaries between therapeutics, medical technologies, consumer devices and
information technology (IT). This rapidly evolving superfluid market is putting pressure on the life sciences
(LS) companies to change their business models and personalize their products and services. The question life
sciences companies must address urgently is how they should be preparing themselves for the coming future.
BioAsia 2020 explores the capabilities that Life sciences companies should invest in Today to thrive and
create value Tomorrow.
Hon’ble Minister for Commerce and Industry, Government of India
Mr. KT Rama Rao
Hon’ble Minister for Industries and Commerce, Government of Telangana
Dr. Carl June
University of Pennsylvania, USA
Dr. Vas Narasimhan
Global Head of Drug Dev. & CMO, Novartis, Switzerland (2017)
Dr. Peter Piot
Director of the London School of Hygiene & Tropical Medicine and Professor of Global Health, UK
Dr. Paul Stoffels
Worldwide Chairman - Pharma, EVP & CSO, Johnson & Johnson, USA (2017)
Dr. Amrit Ray
President R&D and Medical, Pfizer Upjohn, USA
Mrs. Kiran Mazumdar Shaw
Chairman & Managing Director, Biocon Ltd.
Mr. Dilip Shanghvi
Managing Director, Sun Pharma
Mr. Ajay Piramal
Chairman, Piramal Group
Mr. Satish Reddy
Chairman, Dr. Reddy's Laboratories Ltd.
Mr. Jan Van Acker
President, Emerging Markets, MSD
BioAsia 2020 will bring together the global industry leaders, researchers,
policy makers, innovators, and investors together on one platform to deliberate on adapting business models today to catering to the changes of tomorrow.
High Profile Speakers
Advancing global health through affordable innovation